Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05994261 · ClinicalTrials.gov registry record · NA

Cereset Research Long-Term Healthcare Worker Study

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
94
Enrollment target

NCT05994261 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 94 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05994261, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target

Study Summary

Randomized, controlled study of long-term maintenance Cereset Research after an initial 4-session intervention bolus versus usual care control following an initial 4-session intervention bolus.

Interventions

  • DEVICE Cereset Research

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2023-11-06
Est. Completion 2025-07-01
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT05994261

The ClinicalTrials.gov registry entry for NCT05994261 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cereset Research is the first listed.

NCT05994261 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05994261 about?

NCT05994261 is a clinical study titled "Cereset Research Long-Term Healthcare Worker Study". Randomized, controlled study of long-term maintenance Cereset Research after an initial 4-session intervention bolus versus usual care control following an initial 4-session intervention bolus.

What is the current status of trial NCT05994261?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2023-11-06. Estimated completion is 2025-07-01.

What interventions are being tested in trial NCT05994261?

The interventions under investigation include: Cereset Research (DEVICE).

Who is sponsoring clinical trial NCT05994261?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.